Various chromosomal rearrangements result in ALK fusions with oncogenic activity in NSCLC, with nearly 20 different ALK-fusion proteins described in the literature, including EML4–ALK, the most common ALK fusion in NSCLC [26]. Here, ALK is linked to non-small cell lung carcinoma.